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Abstract-The effects of tetanus toxin and its light and heavy chain subunits on vasopressin release were 
investigated in digitonin-permeabilized neurosecretory nerve terminals isolated from the neural lobe ofthe 
rat pituitary gland. Exocytosis was induced by chal1enging the permeabilized nerve endings with 
micromolar calcium concentrations. Tetanus toxin inhibited vasopressin release only in the presence of 
the reducing agent dithiothreitol. This effect was irreversible. The purified light chain of tetanus toxin 
strongly inhibited exocytosis in a dose-dependent manner with half-maximal effect at c. 10 nM. The action 
of the light chain was observed after only 2.5 min of preincubation. Separated heavy chain subunit had 
no effect on hormone secretion. Inhibition ofvasopressin release could be prevented by preincubating the 
light chain of tetanus toxin with an immune serum against tetanus toxin. 
The data c1early demonstrate that in mammalian neurosecretory nerve endings tetanus toxin acts at a 
step downstream from the activation by Ca2+ ofthe exocytotic machinery and that the functional domain 
of this toxin is confined to its light chain. 
In recent years, increasing use has been made of 
bacterial, plant and animal toxins in neurobiological 
research. A potent bacterial neurotoxin synthesized 
as a single-chain protein by Clostridium telani is 
tetanus toxin (for reviews see Refs 13, 24). Sub-
sequent proteolytic processing leads to a pharmaco-
logically more active molecule27 which consists of 
disulfide-Iinked heavy (100,000 mol. wt) and light 
(50,000 mol. wt) chains. Tetanus toxin is a potent 
inhibitor of neurotransmitter secretion from neuronal 
tissue. For example, neurotransmitter release at cen-
tral inhibitory synapses,17 at neuromuscular junc-
tions l8 or at nerve endings of the neurohypophysis l4 
is strongly reduced in the presence of the toxin. It has 
been shown that the individual chains of tetanus 
toxin alone are not neurotoxic in vivo. 16 Application 
of tetanus toxin to intact cells in culture or intoxi-
cation in vivo requires hours before transmitter re-
lease is blocked. This delay refiects the time required 
for the binding of the toxin to the plasma membrane 
followed by intemalization and intracellular action 
(cf. Ref. 13). In vertebrates the domain binding 
to the cell surface appears to be localized at the 
C-terminal of the heavy chain (cf. Ref. 24). 
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Extracellular application of tetanus toxin does not 
allow the differentiation of the intracellular processes 
involved in the final inhibition of neurotransmitter 
release and the role played by the individual chains 
of the toxin. When directly injected into adrenal 
medullary chrom affin cells, tetanus toxin inhibits 
exocytosis. 22 Also, in permeabilized chromaffin cells, 
tetanus toxin tumed out to be a potent inhibitor of 
catecholamine secretion. 1•7 In addition it has been 
shown that the light chain alone is capable of block-
ing exocytosis when introduced directly into cultured 
adrenal chromaffin cells.2•6 
Recently, using permeabilized adrenal chromaffin 
cells or isolated mammalian neurosecretory nerve 
terminals, it has been demonstrated that intracellular 
application of the c10sely related neurotoxin 
botulinum A toxin is more effective in the presence of 
a reducing agent. IO•25 Furthermore it has been found 
that the light chain of botulinum A toxin alone 
inhibits Ca2 + -stimulated catecholamine secretion5,26 
and vasopressin release from nerve terminals, 10 In the 
present study mammalian permeabilized neuro-
secretory nerve terminals were used to address the 
intra-terminal effect of tetanus toxin on neurohypo-
physial hormone release. 
EXPERIMENTAL PROCEDURES 
Male Wistar rats (CharIes River, Sulzfeld, F.R.G.) of 
250-300 g body weight were decapitated and the neural lobe 
was washed with normal Locke saline containing (in mM): 
NaCI, 140; KHCOJ, 5; MgCI2, I; CaCI2, 2.2; Tris-HEPES, 
10; glucose, 10; bovine serum albumin (Miles Laboratories, 
U.S.A.), 0.025%, pH 7.25. The medium was then replaced 
with a buffer containing 270 mM sucrose, 10 mM Tris-
489 
490 G. DAYANITHl et al. 
HEPES, and 2 mM EGT A. The nerve endings were then 
isolated as described by Cazalis et al.9 Briefty, the neuro-
hypophyses were homogenized in the buffered sucrose sol-
ution and centrifuged at 100 g for Imin. The supernatant 
was taken and centrifuged further at 2400 g for 5 min. The 
pellet contains mostly isolated nerve endings as judged by 
electron microscopy.20 Throughout the isolation procedure 
and the experiment the temperature was maintained at 
37°C. The nerve endings were then resuspended in normal 
Locke solution and loaded onto 0.2-/Lm Gelman filters 
(Acro, LC 13). 
The isolated nerve endings were perifused by means 01' a 
multichannel peristaltic pump (Ismatec IPN 8) for 60 min 
with normal Locke at a ftow rate of 50/Llfmin which was 
then increased to 100 /LI/min until the end ofthe experiment. 
Thc perifusion was further continued with normal Locke 
containing no Ca2+ but 5 mM EGTA for 10 min. The 
medium was then replaced by K + -glutamate buffer 
(medium B) containing (in mM): K + -glutamate, 130; 
MgCl1, 2; EGTA, 5; glucose, 10; piperazine-N-N'-bis/2-
ethanesulfonic acid (PIPES), 20; bovine serum albumin, 
0.025%, pH 6.8, and the perifusion run for a further 30 min. 
For pefmeabilization, the nerve endings were perifused for 
5 min with I /LM digitonin in medium B. Subsequently, the 
terminals were perifused for 25 min with the various rorms 
of tetanus toxin dissolved in medium B supplemented with 
1 mM dithiothreitol (DTT). Stimulation was performed for 
10 min with medium B supplemented with 10 /LM ffee Ca2+. 
Collection of the perfusate by means of a fraction collector 
(Gilson-203) started 130 min after loading, i.e. 6 min before 
the Ca2 + stimulation. Fractions were collected every 2 min 
and immediately frozen until radioimmunoassay for 
released arginine vasopressin (AVP) was performed.a The 
Ca< , -evoked hormone release was calculated by subtracting 
the mean basal release determined in the fractions preceding 
the onset ofthe Ca2+ stimulus from the amount of hormone 
found in each of the following eight fractions. 9 Free Ca2 , 
concentrations were ca1culated and controlIed with a Ca2 +-
sensitive electrode. 3.12 
Tetanus toxin was separated into its heavy and light 
chains by isoelectric focusing in a sucrose gradient with 
ampholyte under reducing conditions in 2 mol/l urea.27•2R 
The isoelectric points were 5.9, 4.8, and 7.2 for tetanus toxin, 
its light and heavy chain, respectively. Toxicity (LD50, s.c. in 
mice) was 2 ng/kg for the toxin 100-300 /Lg/kg for the heavy 
chain and 30-40/Lg/kg for the light chain. Before use. all 
toxin preparations were dialysed against medium B. 
Tetanus toxin-antiserum, an immune serum from horse 
(5000 lU/mI), was obtained from Behring Werke, Marburg, 
F.R.G., and dialysed against medium B before use. 
RESULTS 
A typical secretory response of digitonin-permeabi-
lized nerve endings challenged with Ca" + following 
incubation with tetanus toxin (two-chain form) in the 
presence or the absence of a reducing agent DTT is 
shown in Fig. I. In the presence of DTT, inhibition 
of the Ca" + -induced A VP release was observed after 
incubation of the permeabilized nerve endings with 
the toxin during aperiod of25 min. In contrast, in the 
absence of the reducing agent, tetanus toxin had no 
effect on the magnitude and the time-course of the 
secretory response. Inhibition of evoked A VP release 
was observed at a concentration as low as 5 nM 
but this inhibitory effect was only observed in the 
presence of DTT. 
The effect of tetanus toxin on A VP release during 
two successive stimulations with 10 JtM free Ca" + is 
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Fig. I. Tetanus toxin inhibits Ca2 + -induced A VP release 
from permeabilized nerve terminals in the presence of DIT. 
Following permeabilization, the nerve endings were incu-
bated for 25 min at 37°C with various amounts of tetanus 
toxin (Tetx) with or without DIT (I mM). A VP release was 
triggered by challenging the nerve endings with 10 /L M free 
CaH . Each value represents the mean ± S.E.M. of three 
experiments except that at 5 nM tetanus toxin in the absence 
of DIT for which the two values (closed cirdes) are 
indicated. The release caused by 15 nM tetanus toxin in the 
presence of DTT differs significantly (P < 0.01) from that in 
the absence of DIT. 
shown in Fig. 2. When, following a first Ca" + chal-
lenge, the nerve endings from control experiments 
were exposed to a second Ca2+ challenge, 34 min 
later they showed a robust secretory response. How-
ever, when permeabilized nerve endings were incu-
bated for aperiod of 25 min with 50 nM tetanus toxin 
in the presence of DTT, significant inhibition of 
Ca2 + -stimulated release was already observed during 
the first Ca"+ challenge. When compared to the 
control experiment the toxin-treated nerve endings 
were then challenged with a second Ca2 + pulse, they 
showed no recovery of the secretory response after 
the 34 min washout period in the absence of the toxin. 
Thus, the effect of the toxin is irreversible. 
In order to determine the minimum time required 
for the toxin to exert an inhibitory effect on A VP 
release, permeabilized nerve terminals were incubated 
in the presence of the toxin (79 nM) for different 
periods of time. We found that a treatment of only 
2.5 min with the toxin was sufficient to give an 
inhibition of exocytosis by 44.2% while after 25 min 
an inhibition by 55.6% occurred. 
The dose dependence of the inhibition of secretion 
by the light chain of tetanus toxin is illustrated in 
Fig. 3. ICso was observed at a concentration of 
c. 10 nM. Note that high concentrations of the toxin 
did not completely abolish the Ca2 + -induced A VP 
release. The inhibitory effect of tetanus toxin light 
chain on stimulated A VP secretion was fully over-
come by preincubating, before its addition to the 
nerve endings preparation, the light chain with an 
immune serum against tetanus toxin. The results are 
shown in Fig. 4. They demonstrate the specificity of 
the toxin on the secretory process. 
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Fig. 2. Effect of tetanus toxin on A VP release from permeabilized nerve terminals during two successive 
challenges with Ca2 +. The isolated nerve endings were perfused with buffer (medium B). After 
permeabilization they were preincubated for 25 min with or without 50 nM tetanus toxin in the presence 
of DTT (1 mM) which was also present in control experiments. The nerve endings were then challenged 
with 10.uM free Ca2 + for 10 min. After a washout period of 35 min in the absence of free Ca2+ the nerve 
endings were challenged again with lO.uM free Ca2 + for 10 min. Vasopressin release was measured in each 
fraction (2 min). The open circles represent AVP secretion from tetanus toxin-treated nerve terminals and 
the closed circIes represent that from control experiments. Values are expressed as mean ± S.E.M. (n = 4). 
In order to find out whether the light chain of 
tetanus toxin alone is responsible for the observed 
effects or whether the heavy chain modifies the action 
of the light chain, equimolar (10 nM) concentrations 
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Fig. 3. Dose--response curve of the inhibitory effect of 
tetanus toxin light chain on Ca2 + -stimulated vasopressin 
release from permeabilized nerve terminals. Permeabilized 
nerve endings were preincubated for 25 min with increasing 
amounts of tetanus toxin (Tetx) light chain (abscissa). The 
experimental details are the same as in Fig. 2. Caz+ -evoked 
A VP release is expressed as nanograms. The values are 
expressed as the mean of three to five experiments ± S.E.M. 
ofheavy and light chains were applied simultaneously 
as weIl as separately. In contrast to the light chain, 
the heavy chain itself had no effect on AVP release 
(Fig. 4). Furthermore, the heavy chain did not modify 
the effect of the light chain on hormone secretion. 
DlSCUSSION 
Tetanus toxin and botulinum toxins are extremely 
potent neurotoxins produced by the anaerobic bac-
teria of the Clostridium genus. In several in vitro 
studies it has been demonstrated that tetanus toxin 
blocks the release of both inhibitory and excitatory 
neurotransmitters from a number of neuronal cell 
types. However, the effects of tetanus toxin and the 
separated chains on neurohormone release are still 
not known. Isolated neurosecretory nerve terminals 
from the posterior pituitary are an ideal preparation 
to study the action of neurotoxins, because they can 
be permeabilized and the intra-terminal regulation of 
exocytosis can be analysed.9•21 Using the above 
model, we present the first report on intracellular 
action of tetanus toxin in a mammalian neuron. 
The results reported here indicate that the two-
chain form of tetanus toxin inhibits more effectively 
the Ca2 + -stimulated AVP release in the presence of 
a reducing agent, suggesting that the disulfide bridge 
which links the heavy and the light chain ofthe toxin 
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Fig. 4. Specificity of the elfect of tetanus toxin (Tetx) light 
chain on Ca2 + -evoked vasopressin release from permeabi-
lized nerve terminals. The experimental procedure was the 
same as in Fig. 2. The permeabilized nerve terminals were 
either preincubated with bulfer (control), or with 10 nM 
heavy (H.C.) and light chain (L.c.), alone or after previous 
combination. The elfect of 9.2 IE/ml antitoxin to tetanus 
toxin light chain, an immune serum from horse with or 
without light chain was also investigated. Evoked A VP 
release (percentage of control) with 10 IlM free Ca2+ within 
10 min was expressed as mean offour experiments ± S.E.M. 
Note that the heavy chain has no inhibitory elfec! on 
hormone secretion and does not interfere with the action of 
its light chain. The release was significantly (F < 0.01) 
inhibited by tetanus toxin light chain and tetanus toxin 
heavy chain plus light chain. 
has to be cIeaved before exocytosis can be inhibited. 
Our recent results, obtained with the cIosely related 
botulinum A toxin in permeabilized nerve endings,IO 
are along this line. Similarly, in chrom affin ceHs the 
single-chain form of tetanus toxin in which the light 
and the heavy chain are linked by peptide bonds is 
ineffective, the potency of the two-chain form is 
increased by a reducing agent and the light chain 
alone is fully inhibitory.1.2 
Other lines of evidence from this report indicate 
that the action of tetanus toxin was irreversible and 
removal of toxin does not restore exocytosis. More 
interestingly and of importance for further neurobio-
logical investigations, the action of tetanus toxin on 
A VP secretion in permeabilized nerve endings is very 
rapid (within 2.5 min). Furthermore, increasing the 
preincubation period prior to Ca2 t stimulation did 
not increase the degree of inhibition, a fact which is 
in accordance with an earlier report on permeabilized 
chromaffin cells.7 We suggest, therefore, that the 
minimum time requirement for the action of 
botulinum A toxin on other tissues and tetanus 
toxin on neurohypophysial hormone release is quite 
different, and tetanus toxin action is more rapid than 
botulinum A toxin in the same system. 
Once in a cytosolic compartment the heavy chain, 
which may be necessary for internalization, is no 
longer required for full activity of the light chain. In 
contrast to the light chain, the heavy chain itself has 
no effect on vasopressin release. Furthermore, the 
heavy chain did not modify the effect of the light 
chain on hormone secretion. 
The latter observation is in contrast with results 
obtained with botulinum A toxin, in which the heavy 
chain reduces the inhibitory effect of the light chain. 10 
Thus the properties of vasopressin secretion observed 
here are very similar to catecholamine release. In both 
systems the light chain alone is effective and its action 
is unaffected by the added heavy chain in the case of 
tetanus toxin, while inhibition by the light chain of 
botulinum A toxin is abolished by the added heavy 
chain.2.26 In Ap/ysia cholinergic neurons, the situation 
is completely different; namely, both heavy and light 
chains are necessary to manifest the toxic effect of 
botulinum A toxin.I.\·23 On the other hand, only the 
light chain of tetanus toxin is required for inhibiting 
transmitter release in Ap/ysia neurons and this pro-
cess is not modified by intracellular application of the 
heavy chain. 19 The reason for the differences in the 
action of botulinum A toxin and tetanus toxin in 
mammalian and invertebrate systems is not known 
at present. 80th differences in the sequences of 
botulinum A and tetanus toxin4.l 1 and differences in 
the mechanism of release of neuropeptides from 
mammalian nerve terminals compared to that of 
synaptic vesicles from Aplysia neurons must be taken 
into consideration. 
CONCLUSION 
The present data show that the light chain of 
tetanus toxin is responsible for a strong inhibitory 
effect of neurohormone secretion from mammalian 
nerve endings. Also, it can be concluded that the 
toxin acts at a step downstream from the activation 
by Ca2 + of the exocytotic machinery. The data 
support previous investigations carried out with chro-
maffin cells l .2•6 and extend them to nerve endings, i.e. 
structures directly involved in tetanus toxin-induced 
disease. 
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